C4 Therapeutics, Inc.
CCCC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662579
No open-market purchases or sales by C4 Therapeutics, Inc. insiders were filed in the last 90 days; 147 institutions reported holding it in 13F filings for Q2 2026, worth $547.6M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding C4 Therapeutics, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 113 | 2 | 115 | +4 |
| Shares | 64.4M | 213.4K | 64.1M | −74.9K (−0.1%) |
| Value | $231.8M | $768.3K | $102.6M | −$128.5M (−55.6%) |
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (27)
Institutions that held C4 Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
Sold out (23)
Institutions that held C4 Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Ra Capital Management, L.P. | 4,878,000 | $17.6M |
| Wellington Management Group LLP | 283,705 | $1.02M |
| Sio Capital Management, LLC | 155,000 | $558.0K |
| M&T Bank Corp | 132,715 | $478.1K |
| Cubist Systematic Strategies, LLC | 109,825 | $395.4K |
| Verition Fund Management LLC | 69,628 | $250.7K |
| ExodusPoint Capital Management, LP | 59,654 | $215.0K |
| LMR Partners LLP | 51,000 | $183.6K |
| Balyasny Asset Management LLC | 42,533 | $153.1K |
| Walleye Capital LLC | 40,819 | $146.9K |
| Marshall Wace, LLP | 36,167 | $130.2K |
| Franklin Resources Inc | 34,242 | $123.3K |
| Group One Trading, L.P. | 32,883 | $118.4K |
| Citadel Advisors LLC | 28,616 | $103.0K |
| Engineers Gate Manager LP | 25,555 | $92.0K |
| Y-Intercept (Hong Kong) Ltd | 23,176 | $83.4K |
| Lazard Asset Management LLC | 22,693 | $81.0K |
| Kazazian Asset Management, LLC | 14,250 | $51.3K |
| Point72 (DIFC) Ltd | 11,333 | $40.8K |
| Simplex Trading, LLC | 6,871 | $24.0K |
| R Squared Ltd | 3,310 | $11.9K |
| Skopos Labs, Inc. | 3,033 | $10.9K |
| Caitong International Asset Management Co., Ltd | 15 | $54 |
Not filed for Q1 2025 yet (2)
Institutions that held C4 Therapeutics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 192,424 | $692.7K |
| Caxton Associates LP | 21,002 | $75.6K |